Krka reports 5% net profit growth and extends 27-year dividend streak

Slovenian pharmaceutical company Krka reported a net profit of 260.2 million euros, marking a 5% year-over-year increase. The company continues its long-term trend of consecutive annual dividend growth, signaling sustained financial stability.